The PE Ratio as of May 2025 (TTM) for Global Pharmatech, Inc. (GBLP) is -0.67

According to Global Pharmatech, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.67. This represents a change of -100.00% compared to the average of -19206.87 of the last 4 quarters.

Global Pharmatech, Inc. (GBLP) Historical PE Ratio (quarterly & annually)

How has GBLP PE Ratio performed in the past?

The mean historical PE Ratio of Global Pharmatech, Inc. over the last ten years is -590.67. The current -0.67 PE Ratio has changed -88.66% with respect to the historical average. Over the past ten years (40 quarters), GBLP's PE Ratio was at its highest in in the June 2021 quarter at -24.05. The PE Ratio was at its lowest in in the September 2024 quarter at -73631.49.

Global Pharmatech, Inc. (GBLP) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Global Pharmatech, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Global Pharmatech, Inc. (GBLP) Average PE Ratio

How has GBLP PE Ratio performed in the past?

The current PE Ratio of Global Pharmatech, Inc. (GBLP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Global Pharmatech, Inc. (GBLP) PE Ratio vs. Peers

How is GBLP’s PE Ratio compared to its peers?

Global Pharmatech, Inc.’s PE Ratio is greater than Alpha Teknova, Inc. (-13.23), less than Guardion Health Sciences, Inc. (0.69), greater than Lifecore Biomedical, Inc. (-5.75), greater than Organogenesis Holdings Inc. (-21.66), less than Petros Pharmaceuticals, Inc. (-0.48), greater than Cyclo Therapeutics, Inc. (-0.83), less than Athenex, Inc. (-0.01), less than MedMen Enterprises Inc. (-0.00), greater than Lucy Scientific Discovery Inc. (-1.23), greater than ANI Pharmaceuticals, Inc. (-57.12), less than Alkermes plc (14.36), less than Dr. Reddy's Laboratories Limited (3.56), less than Collegium Pharmaceutical, Inc. (21.54), greater than Pacira BioSciences, Inc. (-11.32), less than Zoetis Inc. (28.65), less than PetIQ, Inc. (69.35), greater than Emergent BioSolutions Inc. (-1.66), greater than Bausch Health Companies Inc. (-39.97), less than Neurocrine Biosciences, Inc. (38.49), greater than Ironwood Pharmaceuticals, Inc. (-65.02), greater than Assertio Holdings, Inc. (-2.63), greater than Deciphera Pharmaceuticals, Inc. (-11.74), greater than Esperion Therapeutics, Inc. (-2.84),

Build a custom stock screener for Global Pharmatech, Inc. (GBLP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Global Pharmatech, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Global Pharmatech, Inc. (GBLP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Global Pharmatech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.